184 related articles for article (PubMed ID: 25287661)
21. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
[TBL] [Abstract][Full Text] [Related]
22. SIGIRR deficiency contributes to CD4 T cell abnormalities by facilitating the IL1/C/EBPβ/TNF-α signaling axis in rheumatoid arthritis.
Teng X; Mou DC; Li HF; Jiao L; Wu SS; Pi JK; Wang Y; Zhu ML; Tang M; Liu Y
Mol Med; 2022 Nov; 28(1):135. PubMed ID: 36401167
[TBL] [Abstract][Full Text] [Related]
23. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
24. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
25. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
26. IL-22 production of effector CD4
Dolff S; Scharpenberg C; Specker C; Kribben A; Witzke O; Wilde B
Eur J Med Res; 2019 Jul; 24(1):24. PubMed ID: 31331400
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus.
Feng X; Wang D; Chen J; Lu L; Hua B; Li X; Tsao BP; Sun L
PLoS One; 2012; 7(12):e51982. PubMed ID: 23284839
[TBL] [Abstract][Full Text] [Related]
28. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
29. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
Abo-Elenein A; Shaaban D; Gheith O
Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
[TBL] [Abstract][Full Text] [Related]
30. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids.
Suárez A; López P; Gómez J; Gutiérrez C
Ann Rheum Dis; 2006 Nov; 65(11):1512-7. PubMed ID: 16606650
[TBL] [Abstract][Full Text] [Related]
31. Expression profile of PU.1 in CD4
Xiang N; Fang X; Sun XG; Zhou YB; Ma Y; Zhu C; Li XP; Wang GS; Tao JH; Li XM
Clin Exp Med; 2021 Nov; 21(4):621-632. PubMed ID: 33966135
[TBL] [Abstract][Full Text] [Related]
32. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
Szmyrka-Kaczmarek M; Kosmaczewska A; Ciszak L; Szteblich A; Wiland P
Postepy Hig Med Dosw (Online); 2014; 68():893-8. PubMed ID: 24988609
[TBL] [Abstract][Full Text] [Related]
34. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
[TBL] [Abstract][Full Text] [Related]
35. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
36. mRNA expression of chemokine receptors on peripheral blood mononuclear cells and correlation with clinical features in systemic lupus erythematosus patients.
Li YM; Chen ZQ; Yao X; Yang AZ; Li AS; Liu DM; Gong JQ
Chin Med Sci J; 2010 Sep; 25(3):162-8. PubMed ID: 21180278
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
38. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
39. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
40. OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.
Farres MN; Al-Zifzaf DS; Aly AA; Abd Raboh NM
Ann Saudi Med; 2011; 31(1):29-34. PubMed ID: 21245596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
